You are certainly correct about me not being well informed and I hardly ever respond about the science or data, etc., because I'm not qualified there at all!....
I just attempt to use the tools I have used over the years and have admittedly pointed out the numerous failures at respected "support levels".....about 4 or 5 of them broken just this past year...!!!
I like Falconer and he has been considerate and helpful, but is in the same boat as all current shareholders.
Has anyone done a welfare check on Falconeer? The poor guy was hoping dividend checks would start rolling in 2026.
Nope. None needed.
Like everyone else I read and ponder each iHUB Anavex posting each day. Nothing new or different. Before the announced negative “leaning” of the European Medicines Agency officials were the persisting Anavex naysayings; which continue with greater leverage. Anavex supporters, who know the unique sigma-1 receptor science owned by Anavex, continue to hope for eventual regulatory approval of blarcamesine, somewhere in the world.
Personally, over the years, I took, incrementally, a very moderate AVXL position, using only discretionary funds in my family budget. Instead of a few fancy vacations to a resort area I bought some AVXLs. If Anavex goes bust I will have lost those dollars. But, as one Anavex naysayer states, investing in young biotechs is not for everyone. I knew that from the start. If Anavex goes bust the rest of my life will be unchanged (unless I get Alzheimer’s, as my father did).
By the way, I'm “Falconer...,” not ‘Falconeer.’ I was a licensed falconer, trapped, banded, trained, and hunted with Red-tailed Hawks, a species that I’ve professionally studied as an ecologist across the U.S. I’m a recognized expert in raptor biology, and a few other areas of biological science. I was also an award-winning teacher of advanced placement biology, where I taught to my talented college-bound students the cellular biology involved in neurodegeneration and the biochemistry of human cells, which the Anavex sigma-1 receptor agonists optimize. Over a dozen of my former students are now biology faculty members or medical specialists; who got college scholarships from what they learned in my classes and the student research projects I guided them on.